Author Nierhaus, Axel
-
2012 | Journal Article
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis A Randomized Trial
Brunkhorst, F. M.; Oppert, M.; Marx, G.; Bloos, F.; Ludewig, K.; Putensen, C. & Nierhaus, A. et al. (2012)
JAMA, 307(22) pp. 2390-2399. DOI: https://doi.org/10.1001/jama.2012.5833
Details DOI PMID PMC WoS
-
2015 | Journal Article |
The use of extracorporeal carbon dioxide removal to avoid intubation in patients failing non-invasive ventilation – a cost analysis
Braune, S.; Burchardi, H.; Engel, M.; Nierhaus, A.; Ebelt, H.; Metschke, M. & Rosseau, S. et al. (2015)
BMC Anesthesiology, 15(1) art. 160. DOI: https://doi.org/10.1186/s12871-015-0139-0
Details DOI PMID PMC
-
2016 | Journal Article
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock A Randomized Clinical Trial
Bloos, F.; Trips, E.; Nierhaus, A.; Briegel, J.; Heyland, D. K.; Jaschinski, U. & Moerer, O. et al. (2016)
JAMA Internal Medicine, 176(9) pp. 1266-1276. DOI: https://doi.org/10.1001/jamainternmed.2016.2514
Details DOI PMID PMC WoS
-
2018 | Journal Article |
Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
Winkler, M. S; Nierhaus, A.; Rösler, G.; Lezius, S.; Harlandt, O.; Schwedhelm, E. & Böger, R. H et al. (2018)
Critical Care, 22(1) art. 216. DOI: https://doi.org/10.1186/s13054-018-2090-1
Details DOI
-
2018 | Journal Article |
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial
Elke, G.; Bloos, F.; Wilson, D. C.; Brunkhorst, F. M.; Briegel, J.; Reinhart, K. & Loeffler, M. et al. (2018)
Critical Care, 22(1). DOI: https://doi.org/10.1186/s13054-018-2001-5
Details DOI
-
2019 | Journal Article |
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
Winkler, M. S.; Märtz, K. B.; Nierhaus, A.; Daum, G.; Schwedhelm, E.; Kluge, S. & Gräler, M. H. (2019)
Journal of Intensive Care, 7(1) art. 23. DOI: https://doi.org/10.1186/s40560-019-0376-2
Details DOI PMID PMC
-
2020 | Journal Article
S1P lyase inhibition protects against sepsis by promoting disease tolerance via the S1P/S1PR3 axis
Weigel, C.; Hüttner, S. S.; Ludwig, K.; Krieg, N.; Hofmann, S.; Schröder, N. H. & Robbe, L. et al. (2020)
EBioMedicine, 58 pp. 102898. DOI: https://doi.org/10.1016/j.ebiom.2020.102898
Details DOI
-
2020 | Journal Article |
Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial
Sakr, Y.; Bauer, M.; Nierhaus, A.; Kluge, S.; Schumacher, U.; Putensen, C. & Fichtner, F. et al. (2020)
Trials, 21(1). DOI: https://doi.org/10.1186/s13063-020-04921-y
Details DOI
-
2021 | Journal Article |
Dynamics of Vascular Protective and Immune Supportive Sphingosine-1-Phosphate During Cardiac Surgery
Greiwe, G.; Moritz, E.; Amschler, K.; Poppe, A.; Sarwari, H.; Nierhaus, A. & Kluge, S. et al. (2021)
Frontiers in Immunology, 12. DOI: https://doi.org/10.3389/fimmu.2021.761475
Details DOI